These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 28560532)

  • 1. Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
    Ogura K; Gokita T; Shinoda Y; Kawano H; Takagi T; Ae K; Kawai A; Wedin R; Forsberg JA
    Clin Orthop Relat Res; 2017 Sep; 475(9):2263-2270. PubMed ID: 28560532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
    Forsberg JA; Wedin R; Boland PJ; Healey JH
    Clin Orthop Relat Res; 2017 Apr; 475(4):1252-1261. PubMed ID: 27909972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
    Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
    Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a Bayesian Belief Network Be Used to Estimate 1-year Survival in Patients With Bone Sarcomas?
    Nandra R; Parry M; Forsberg J; Grimer R
    Clin Orthop Relat Res; 2017 Jun; 475(6):1681-1689. PubMed ID: 28397168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.
    Piccioli A; Spinelli MS; Forsberg JA; Wedin R; Healey JH; Ippolito V; Daolio PA; Ruggieri P; Maccauro G; Gasbarrini A; Biagini R; Piana R; Fazioli F; Luzzati A; Di Martino A; Nicolosi F; Camnasio F; Rosa MA; Campanacci DA; Denaro V; Capanna R
    BMC Cancer; 2015 May; 15():424. PubMed ID: 25998535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of PATHFx 2.0: An open-source tool for estimating survival in patients undergoing pathologic fracture fixation.
    Overmann AL; Clark DM; Tsagkozis P; Wedin R; Forsberg JA
    J Orthop Res; 2020 Oct; 38(10):2149-2156. PubMed ID: 32492213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities.
    Sørensen MS; Gerds TA; Hindsø K; Petersen MM
    Clin Orthop Relat Res; 2018 Aug; 476(8):1591-1599. PubMed ID: 30020148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are Current Survival Prediction Tools Useful When Treating Subsequent Skeletal-related Events From Bone Metastases?
    Pan YT; Lin YP; Yen HK; Yen HH; Huang CC; Hsieh HC; Janssen S; Hu MH; Lin WH; Groot OQ
    Clin Orthop Relat Res; 2024 Sep; 482(9):1710-1721. PubMed ID: 38517402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief network.
    Forsberg JA; Eberhardt J; Boland PJ; Wedin R; Healey JH
    PLoS One; 2011; 6(5):e19956. PubMed ID: 21603644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can a Bayesian belief network for survival prediction in patients with extremity metastases (PATHFx) be externally validated in an Asian cohort of 356 surgically treated patients?
    Hsieh HC; Lai YH; Lee CC; Yen HK; Tseng TE; Yang JJ; Ling SY; Hu MH; Hou CH; Yang RS; Wedin R; Forsberg JA; Lin WH
    Acta Orthop; 2022 Sep; 93():721-731. PubMed ID: 36083697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating metastatic disease: Which survival model is best suited for the clinic?
    Forsberg JA; Sjoberg D; Chen QR; Vickers A; Healey JH
    Clin Orthop Relat Res; 2013 Mar; 471(3):843-50. PubMed ID: 22983682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.
    Lee CC; Chen CW; Yen HK; Lin YP; Lai CY; Wang JL; Groot OQ; Janssen SJ; Schwab JH; Hsu FM; Lin WH
    Clin Orthop Relat Res; 2024 Dec; 482(12):2193-2208. PubMed ID: 39051924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2015 Marshall Urist Young Investigator Award: Prognostication in Patients With Long Bone Metastases: Does a Boosting Algorithm Improve Survival Estimates?
    Janssen SJ; van der Heijden AS; van Dijke M; Ready JE; Raskin KA; Ferrone ML; Hornicek FJ; Schwab JH
    Clin Orthop Relat Res; 2015 Oct; 473(10):3112-21. PubMed ID: 26155769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of the PATHFx decision-support tool on Turkish patients with skeletal metastasis.
    Ozkan K; Ozturan B; Karadag Z; Erol B; Alpan B; Ozger H; Gurkan V; Sofulu O; Yalcinkaya M; Okay E; Forsberg JA
    Indian J Cancer; 2023 Feb; ():. PubMed ID: 36861722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Presence of Missing Data Affect the Performance of the SORG Machine-learning Algorithm for Patients With Spinal Metastasis? Development of an Internet Application Algorithm.
    Huang CC; Peng KP; Hsieh HC; Groot OQ; Yen HK; Tsai CC; Karhade AV; Lin YP; Kao YT; Yang JJ; Dai SH; Huang CC; Chen CW; Yen MH; Xiao FR; Lin WH; Verlaan JJ; Schwab JH; Hsu FM; Wong T; Yang RS; Yang SH; Hu MH
    Clin Orthop Relat Res; 2024 Jan; 482(1):143-157. PubMed ID: 37306629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of Postoperative Clinical Recovery of Drop Foot Attributable to Lumbar Degenerative Diseases, via a Bayesian Network.
    Takenaka S; Aono H
    Clin Orthop Relat Res; 2017 Mar; 475(3):872-880. PubMed ID: 27913961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastases.
    Forsberg JA; Wedin R; Bauer HC; Hansen BH; Laitinen M; Trovik CS; Keller JØ; Boland PJ; Healey JH
    BMC Cancer; 2012 Oct; 12():493. PubMed ID: 23098538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting survival of patients with spinal metastatic disease using PathFx 3.0 - A validation study of 668 patients in Sweden.
    Carrwik C; Tsagkozis P; Wedin R; Robinson Y
    Brain Spine; 2022; 2():101669. PubMed ID: 36506283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Machine learning algorithms to estimate 10-Year survival in patients with bone metastases due to prostate cancer: toward a disease-specific survival estimation tool.
    Anderson AB; Grazal C; Wedin R; Kuo C; Chen Y; Christensen BR; Cullen J; Forsberg JA
    BMC Cancer; 2022 Apr; 22(1):476. PubMed ID: 35490227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Validation of the SORG Machine-learning Algorithm for Predicting the Survival of Patients with Extremity Metastases Undergoing Surgical Treatment.
    Tseng TE; Lee CC; Yen HK; Groot OQ; Hou CH; Lin SY; Bongers MER; Hu MH; Karhade AV; Ko JC; Lai YH; Yang JJ; Verlaan JJ; Yang RS; Schwab JH; Lin WH
    Clin Orthop Relat Res; 2022 Feb; 480(2):367-378. PubMed ID: 34491920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.